These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

996 related items for PubMed ID: 17877767

  • 1. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G, Ajayi Y, Stern ME, Calder VL.
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [Abstract] [Full Text] [Related]

  • 2. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A, Quintieri L.
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
    Fujishima H, Ohashi Y, Takamura E.
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
    [Abstract] [Full Text] [Related]

  • 6. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.
    Ahluwalia P, Anderson DF, Wilson SJ, McGill JI, Church MK.
    J Allergy Clin Immunol; 2001 Sep; 108(3):449-54. PubMed ID: 11544467
    [Abstract] [Full Text] [Related]

  • 7. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A, Ishida W, Ojima A, Kajisako M, Sumi T, Yamada J, Tsuru E, Miyazaki J, Tominaga A, Yagita H.
    Int Arch Allergy Immunol; 2010 Sep; 151(2):129-36. PubMed ID: 19752566
    [Abstract] [Full Text] [Related]

  • 8. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H.
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G.
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [Abstract] [Full Text] [Related]

  • 11. Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells.
    Cook EB, Stahl JL, Barney NP, Graziano FM.
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):424-9. PubMed ID: 11730187
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [Abstract] [Full Text] [Related]

  • 13. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis.
    Bundoc VG, Keane-Myers A.
    Exp Eye Res; 2007 Oct; 85(4):575-9. PubMed ID: 17765892
    [Abstract] [Full Text] [Related]

  • 14. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.
    Andersen HB, Holm M, Hetland TE, Dahl C, Junker S, Schiøtz PO, Hoffmann HJ.
    J Immunol Methods; 2008 Jul 31; 336(2):166-74. PubMed ID: 18538784
    [Abstract] [Full Text] [Related]

  • 15. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
    Fukuda K, Ohbayashi M, Morohoshi K, Zhang L, Liu FT, Ono SJ.
    J Allergy Clin Immunol; 2009 Oct 31; 124(4):827-33.e2. PubMed ID: 19660804
    [Abstract] [Full Text] [Related]

  • 16. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.
    Macleod JD, Anderson DF, Baddeley SM, Holgate ST, McGill JI, Roche WR.
    Clin Exp Allergy; 1997 Nov 31; 27(11):1328-34. PubMed ID: 9420138
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM, Tekelioglu Y, Turk A, Akyol N.
    Clin Ther; 2005 Sep 31; 27(9):1392-402. PubMed ID: 16291412
    [Abstract] [Full Text] [Related]

  • 18. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T, Miyazaki D, Sasaki S, Mihara S, Komatsu N, Yakura K, Inoue Y.
    Invest Ophthalmol Vis Sci; 2009 Nov 31; 50(11):5181-8. PubMed ID: 19553621
    [Abstract] [Full Text] [Related]

  • 19. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA.
    J Ocul Pharmacol Ther; 1996 Nov 31; 12(4):389-400. PubMed ID: 8951675
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.